MedImmune LLC acquires Spirogen Ltd.

On October 15, 2013, MedImmune LLC acquired Spirogen Ltd., a life science company in United Kingdom, from Auven Therapeutics.

Deal at a glance

AnnouncedOctober 15, 2013 TypeAdd-on Acquistion TargetSpirogen Ltd. Buyer MedImmune LLC Seller Auven Therapeutics SectorLife Science LocationUnited Kingdom ValueMembers only

Target company

Spirogen Ltd.

United Kingdom

Life Sciencesector

-founded

Activestatus

View the company profile →

Buyer

MedImmune LLC

Company · 6 deals on record

4th transaction in life science
1st transaction in United Kingdom

6deals, all time

5in this sector

2013latest

Seller

Auven Therapeutics

Company · 4 deals on record

4investments

4in this sector

3exits

Members only

Contact details at the buyers and sellers

The full deal history of every party

Co-investors and the other advisors on this deal

Deal value and revenue or EBITDA multiples

Related deals

Drug Development SolutionsSame sector and country · May 2022

Aptus Clinical Ltd.Same sector and country · May 2022

Panthera BiopartnersSame sector and country · Apr 2022

Questions about this deal

Who acquired Spirogen Ltd.?MedImmune LLC acquired Spirogen Ltd. on October 15, 2013.

Who sold Spirogen Ltd.?Auven Therapeutics was the seller.

What type of deal was it?It was a add-on acquistion in the life science sector in 2013.

See the full picture on AcquityDataContacts, full deal histories, co-investors and deal values. Free for a day with your Google account, no card needed.

Try it free

Data updated daily on AcquityData (Acquity Data).